Elevated levels of beta-C-terminal telopeptide (ctx) indicate increased bone resorption. Increased levels are associated with osteoporosis, osteopenia, Paget disease, hyperthyroidism, and hyperparathyroidism. In patients taking antiresorptive agents (bisphosphonates or hormone replacement therapy), a decrease of 25\% or more from baseline beta-ctx levels (ie, prior to the start of therapy) 3 to 6 months after initiation of therapy indicates an adequate therapeutic response.Read more

• 8-12 hour fasting is mandatory.

• The Ceruloplasmin Test price varies by city and healthcare provider, starting from ₹750 to ₹1460